Clinical Trial Update: Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating aripiprazole and D-cycloserine for symptoms of autism has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autistic Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)
• D-cycloserine (D-cycloserine)

Snippet

Sponsor: Indiana University | Conditions: Autistic Disorder | Phase 3 | Status: COMPLETED | Results posted: 2019-03-29